Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 2:30 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 500459 | NSE: PGHH

Procter & Gamble Hygiene and Health Care Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹6,507.40Overvalued by 33.24%vs CMP ₹9,748.00

P/E (36.8) × ROE (75.7%) × BV (₹287.00) × DY (1.74%)

₹3,784.97Overvalued by 61.17%vs CMP ₹9,748.00
MoS: -157.5% (Negative)Confidence: 66/100 (Moderate)Models: 1 Fair, 9 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹7,050.3120%Over (-27.7%)
Graham NumberEarnings₹1,307.6014%Over (-86.6%)
Earnings PowerEarnings₹1,717.6412%Over (-82.4%)
DCFCash Flow₹4,113.3212%Over (-57.8%)
Net Asset ValueAssets₹286.876%Over (-97.1%)
EV/EBITDAEnterprise₹3,338.288%Over (-65.8%)
Dividend DiscountDividends₹9,332.358%Fair (-4.3%)
Earnings YieldEarnings₹2,647.806%Over (-72.8%)
ROCE CapitalReturns₹2,632.178%Over (-73%)
Revenue MultipleRevenue₹1,559.455%Over (-84%)
Consensus (10 models)₹3,784.97100%Overvalued
Key Drivers: Wide model spread (₹287–₹9,332) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 8.3%

*Investments are subject to market risks

Investment Snapshot

71
Procter & Gamble Hygiene and Health Care Ltd scores 71/100 (Strong)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health88/100 · Strong
ROCE 104.0% ExcellentROE 75.7% ExcellentD/E 0.00 Low debtInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money65/100 · Strong
FII holding stable No changeDII holding up 0.53% MF buyingPromoter holding at 70.6% Stable
Earnings Quality65/100 · Strong
OPM expanding (22% → 25%) Improving
Quarterly Momentum58/100 · Moderate
Revenue (4Q): 1% YoY FlatProfit (4Q): +20% YoY Positive
Industry Rank65/100 · Strong
P/E 36.8 vs industry 46.9 In-lineROCE 104.0% vs industry 29.2% Above peersROE 75.7% vs industry 23.9% Above peers3Y sales CAGR: -5% Shrinking

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 2:30 am

Market Cap 31,636 Cr.
Current Price 9,748
Intrinsic Value₹3,784.97
High / Low 14,543/8,979
Stock P/E36.8
Book Value 287
Dividend Yield1.74 %
ROCE104 %
ROE75.7 %
Face Value 10.0
PEG Ratio4.41

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Procter & Gamble Hygiene and Health Care Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Procter & Gamble Hygiene and Health Care Ltd 31,636 Cr. 9,748 14,543/8,97936.8 2871.74 %104 %75.7 % 10.0
Godrej Industries Ltd 28,017 Cr. 832 1,392/74427.8 3090.00 %7.83 %9.64 % 1.00
Gillette India Ltd 24,566 Cr. 7,538 11,505/7,20639.6 3571.59 %56.1 %41.6 % 10.0
Emami Ltd 17,174 Cr. 393 655/38521.4 67.12.54 %32.4 %30.2 % 1.00
Colgate-Palmolive (India) Ltd 49,493 Cr. 1,820 2,747/1,78237.1 58.22.80 %105 %81.2 % 1.00
Industry Average60,427.93 Cr1,572.1446.89111.991.02%29.21%23.91%4.94

All Competitor Stocks of Procter & Gamble Hygiene and Health Care Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 1,1378838531,1381,1331,0029321,1351,2489929371,1501,262
Expenses 847734638853824745813845877782671865860
Operating Profit 290149215285310257118290371210266285402
OPM % 26%17%25%25%27%26%13%26%30%21%28%25%32%
Other Income 9141016161478101981012
Interest 4432322-0276043
Depreciation 141515141415131210109910
Profit before tax 282146207284309234112285364213265282402
Tax % 26%-13%27%26%26%34%28%26%26%27%27%26%25%
Net Profit 20716515121122915481212269156192210301
EPS in Rs 63.9150.8446.5964.9170.5247.5624.9765.2882.7448.0959.1764.6592.87

Last Updated: February 7, 2026, 12:03 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 18, 2026, 11:51 am

MetricJun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025n n 9mTTM
Sales 2,0512,3342,2752,3202,4552,9473,0023,5743,9013,9184,2063,3744,341
Expenses 1,6281,8381,6671,6461,8342,3292,3962,6883,0693,0483,2302,5033,178
Operating Profit 4234956086756226186068868328699768711,162
OPM % 21%21%27%29%25%21%20%25%21%22%23%26%27%
Other Income 78648567184542382340473749
Interest 5661055661111271412
Depreciation 35535260525048485358563238
Profit before tax 4605016366725826075948707908399398621,161
Tax % 34%31%34%36%36%31%27%25%27%19%28%26%
Net Profit 302346422433375419433652576678675637859
EPS in Rs 93.04106.63130.16133.31115.40129.12133.42200.79177.37208.91207.95196.11264.78
Dividend Payout % 30%28%28%292%35%68%79%157%90%89%123%89%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year
YoY Net Profit Growth (%)
Change in YoY Net Profit Growth (%)

No data available for trend analysis.

Growth

Compounded Sales Growth
10 Years:5%
5 Years:3%
3 Years:-2%
TTM:3%
Compounded Profit Growth
10 Years:8%
5 Years:8%
3 Years:-1%
TTM:23%
Stock Price CAGR
10 Years:8%
5 Years:6%
3 Years:-1%
1 Year:-16%
Return on Equity
10 Years:52%
5 Years:68%
3 Years:79%
Last Year:76%

Last Updated: September 4, 2025, 9:30 pm

Balance Sheet

Last Updated: December 4, 2025, 12:51 am

MonthJun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Sep 2025
Equity Capital 32323232323232323232323232
Reserves 9701,1961,6194947738771,125682705914742705899
Borrowings 0000000354322
Other Liabilities 5057195156346207086719159401,1871,0811,0151,200
Total Liabilities 1,5081,9482,1661,1601,4251,6171,8281,6331,6832,1371,8591,7552,133
Fixed Assets 240309317286250234206184164170139131166
CWIP 98393541211522384423284114
Investments 0000000000000
Other Assets 1,1701,6001,8148341,1541,3681,6001,4111,4751,9451,6921,5831,953
Total Assets 1,5081,9482,1661,1601,4251,6171,8281,6331,6832,1371,8591,7552,133

Reserves and Borrowings Chart

Cash Flow

MonthJun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025
Cash from Operating Activity + 335426352445415413474863573826470593
Cash from Investing Activity + -13528221149-1934757-27-101-34
Cash from Financing Activity + -95-105-122-1,559-106-314-190-1,106-569-477-861-666
Net Cash Flow 105349452-964290134358-236-23339-390-107
Free Cash Flow 189348300401377410423832523781427539
CFO/OP 105%127%91%103%111%105%102%126%99%121%79%96%

Free Cash Flow

MonthJun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025n n 9m
Free Cash Flow423.00495.00608.00675.00622.00618.00606.00883.00827.00865.00973.00871.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthJun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025
Debtor Days 151824212222201518202133
Inventory Days 534753714860687855485164
Days Payable 103148134145156162175237183213193235
Cash Conversion Cycle -35-83-57-53-87-79-87-144-110-145-121-138
Working Capital Days 4348-15-23-12-21-39-34-53-32-31
ROCE %52%46%45%64%89%73%58%94%110%101%112%104%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 70.64%70.64%70.64%70.64%70.64%70.64%70.64%70.64%70.64%70.64%70.64%70.64%
FIIs 1.05%1.13%1.30%1.48%1.57%1.56%1.48%1.43%1.33%1.38%1.11%1.06%
DIIs 15.44%15.49%15.45%15.29%15.11%15.16%15.28%15.37%15.50%15.49%16.05%16.03%
Public 12.87%12.73%12.61%12.60%12.67%12.65%12.60%12.56%12.52%12.48%12.19%12.25%
No. of Shareholders 39,96839,38837,06938,80739,99940,67142,34842,94144,87747,89149,99750,969

Shareholding Pattern Chart

No. of Shareholders

Procter & Gamble Hygiene and Health Care Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
SBI Focused Fund 900,000 2.46 1058.94N/AN/AN/A
ICICI Prudential Large Cap Fund 532,050 0.82 626.01N/AN/AN/A
SBI Equity Hybrid Fund 430,000 0.62 505.94430,0002025-04-22 15:16:470%
SBI Midcap Fund 280,000 1.47 329.45N/AN/AN/A
Franklin India Mid Cap Fund 103,662 1 121.9788,6622026-02-23 01:54:5616.92%
Sundaram Mid Cap Fund 100,951 0.92 118.7897,7292026-02-22 00:54:453.3%
Aditya Birla Sun Life MNC Fund 69,490 2.39 81.76N/AN/AN/A
UTI MNC Fund 49,185 2.1 57.8738,0102025-12-08 02:04:5529.4%
Aditya Birla Sun Life Consumption Fund 38,899 0.75 45.77N/AN/AN/A
Sundaram Large and Mid Cap Fund 33,000 0.58 38.8334,2362026-01-26 00:54:55-3.61%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Jun 24Jun 23Jun 22Jun 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 196.11207.95208.91177.37200.79
Diluted EPS (Rs.) 196.11207.95208.91177.37200.79
Cash EPS (Rs.) 205.96225.36226.89193.66215.48
Book Value[Excl.RevalReserv]/Share (Rs.) 227.04238.71291.44227.22220.05
Book Value[Incl.RevalReserv]/Share (Rs.) 227.04238.71291.44227.22220.05
Dividend / Share (Rs.) 175.00255.00185.00160.00315.00
Revenue From Operations / Share (Rs.) 1039.561295.661206.991201.761101.09
PBDIT / Share (Rs.) 279.85315.00280.10263.16284.55
PBIT / Share (Rs.) 270.01297.59262.12246.87269.87
PBT / Share (Rs.) 265.61289.34258.62243.42267.99
Net Profit / Share (Rs.) 196.12207.95208.91177.37200.80
PBDIT Margin (%) 26.9224.3123.2021.8925.84
PBIT Margin (%) 25.9722.9621.7120.5424.50
PBT Margin (%) 25.5422.3321.4220.2524.33
Net Profit Margin (%) 18.8616.0517.3014.7518.23
Return on Networth / Equity (%) 86.3787.1171.6878.0691.25
Return on Capital Employeed (%) 102.66110.0380.8597.31109.87
Return On Assets (%) 36.2736.3131.7234.2439.92
Asset Turnover Ratio (%) 1.872.112.052.352.07
Current Ratio (X) 1.231.221.381.321.34
Quick Ratio (X) 0.980.991.181.051.04
Inventory Turnover Ratio (X) 15.103.473.745.224.97
Dividend Payout Ratio (NP) (%) 104.53127.4369.4098.66169.32
Dividend Payout Ratio (CP) (%) 99.53117.5963.9090.36157.79
Earning Retention Ratio (%) -4.53-27.4330.601.34-69.32
Cash Earning Retention Ratio (%) 0.47-17.5936.109.64-57.79
Interest Coverage Ratio (X) 63.5238.1879.9076.34151.17
Interest Coverage Ratio (Post Tax) (X) 45.5226.2160.5952.45107.68
Enterprise Value (Cr.) 43676.2653361.7845454.0942869.0042606.67
EV / Net Operating Revenue (X) 12.9412.6911.6010.9911.92
EV / EBITDA (X) 48.0852.1949.9950.1946.13
MarketCap / Net Operating Revenue (X) 13.0912.8311.8511.1512.11
Retention Ratios (%) -4.53-27.4330.591.33-69.32
Price / BV (X) 59.9269.6349.0858.9960.58
Price / Net Operating Revenue (X) 13.0912.8311.8511.1512.11
EarningsYield 0.010.010.010.010.01

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Procter & Gamble Hygiene & Healthcare Ltd. is a Public Limited Listed company incorporated on 20/07/1964 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1964PLC012971 and registration number is 012971. Currently Company is involved in the business activities of Manufacture of wadding of textile materials and articles of wadding such as sanitary napkins and tampoons. Company's Total Operating Revenue is Rs. 3374.42 Cr. and Equity Capital is Rs. 32.46 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Personal CareP & G Plaza, Cardinal Gracias Road, Mumbai Maharashtra 400099Contact not found
Management
NamePosition Held
Mr. Chittranjan DuaChairman & Ind.Director
Mr. Kumar VenkatasubramanianManaging Director
Mr. Ghanashyam HegdeExecutive Director
Mr. Pramod AgarwalNon Executive Director
Mr. Gagan SawhneyNon Executive Director
Ms. Sonali DhawanNon Executive Director
Mr. Krishnamurthy IyerIndependent Director
Mr. Gurcharan DasIndependent Director
Dr. Ashima GoyalIndependent Director

FAQ

What is the intrinsic value of Procter & Gamble Hygiene and Health Care Ltd and is it undervalued?

As of 15 April 2026, Procter & Gamble Hygiene and Health Care Ltd's intrinsic value is ₹3784.97, which is 61.17% lower than the current market price of ₹9,748.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (75.7 %), book value (₹287), dividend yield (1.74 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Procter & Gamble Hygiene and Health Care Ltd?

Procter & Gamble Hygiene and Health Care Ltd is trading at ₹9,748.00 as of 15 April 2026, with a FY2026-2027 high of ₹14,543 and low of ₹8,979. The stock is currently near its 52-week low. Market cap stands at ₹31,636 Cr..

How does Procter & Gamble Hygiene and Health Care Ltd's P/E ratio compare to its industry?

Procter & Gamble Hygiene and Health Care Ltd has a P/E ratio of 36.8, which is below the industry average of 46.89. This is broadly in line with or below the industry average.

Is Procter & Gamble Hygiene and Health Care Ltd financially healthy?

Key indicators for Procter & Gamble Hygiene and Health Care Ltd: ROCE of 104 % indicates efficient capital utilization; ROE of 75.7 % shows strong shareholder returns. Dividend yield is 1.74 %.

Is Procter & Gamble Hygiene and Health Care Ltd profitable and how is the profit trend?

Procter & Gamble Hygiene and Health Care Ltd reported a net profit of ₹637 Cr in Mar 2025n n 9m on revenue of ₹3,374 Cr. Compared to ₹576 Cr in Jun 2022, the net profit shows an improving trend.

Does Procter & Gamble Hygiene and Health Care Ltd pay dividends?

Procter & Gamble Hygiene and Health Care Ltd has a dividend yield of 1.74 % at the current price of ₹9,748.00. The company pays dividends, though the yield is modest.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Procter & Gamble Hygiene and Health Care Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports